| Application no. and date | 19151824.0 (espacenet) (Federated) (European Patent Register), 20101230 | | Patent/reg. no. and date | DK/EP 3511330, 20200930 | | Publication date | 20190717 | | Priority no. and date | WO PCT/CN2009/076321, 20091231 | | EP pub. no. and date |
EP 3511330 20190717 | | Effective date | | | Applicant/owner | Hutchison Medipharma Limited, 720 Cai Lun Road Building 4
Pudong, Shanghai 201203, CN | | Applicant ref. no. | 1562572 | | Inventor | SU, Wei-Guo, HUTCHISON MEDIPHARMA LTD
720 Cai Lun Road Building 4
Pudong, Shanghai 201203, CN,
JIA, Hong, 720 Cai Lun Road Building 4
Pudong, Shanghai 201203, CN,
DAI, Guangxiu, 720 Cai Lun Road Building 4
Pudong, Shanghai 201203, CN | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB
, GB | | Opponent | | | IPC Class | C07D 471/04 (2006.01) | | Title | SYNTETISK MELLEMPRODUKT, DER ER ANVENDELIGT TIL FREMSTILLING AF TRIAZOLOPYRIDIN-C-MET-INHIBITORER | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
